List of Excipients in API ZIPRASIDONE HYDROCHLORIDE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing ZIPRASIDONE HYDROCHLORIDE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| ROERIG | GEODON | ziprasidone hydrochloride | 0049-3960 | LACTOSE | |
| ROERIG | GEODON | ziprasidone hydrochloride | 0049-3960 | MAGNESIUM STEARATE | |
| ROERIG | GEODON | ziprasidone hydrochloride | 0049-3960 | STARCH, CORN | |
| STAT RX USA LLC | GEODON | ziprasidone hydrochloride | 16590-895 | LACTOSE | |
| STAT RX USA LLC | GEODON | ziprasidone hydrochloride | 16590-895 | MAGNESIUM STEARATE | |
| Rebel Distributors Corp | GEODON | ziprasidone hydrochloride | 21695-060 | LACTOSE | |
| Rebel Distributors Corp | GEODON | ziprasidone hydrochloride | 21695-060 | MAGNESIUM STEARATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing ZIPRASIDONE HYDROCHLORIDE
Detailed excipient profiles for ZIPRASIDONE HYDROCHLORIDE
Excipient focus: ALCOHOL
ZIPRASIDONE HYDROCHLORIDE drug variants containing ALCOHOL
ZIPRASIDONE HYDROCHLORIDE drug variants not containing ALCOHOL
Excipient focus: AMMONIA
ZIPRASIDONE HYDROCHLORIDE drug variants containing AMMONIA
ZIPRASIDONE HYDROCHLORIDE drug variants not containing AMMONIA
Excipient focus: AMMONIUM CHLORIDE
ZIPRASIDONE HYDROCHLORIDE drug variants containing AMMONIUM CHLORIDE
ZIPRASIDONE HYDROCHLORIDE drug variants not containing AMMONIUM CHLORIDE
Excipient focus: ANHYDROUS LACTOSE
ZIPRASIDONE HYDROCHLORIDE drug variants containing ANHYDROUS LACTOSE
ZIPRASIDONE HYDROCHLORIDE drug variants not containing ANHYDROUS LACTOSE
Excipient focus: BUTYL ALCOHOL
ZIPRASIDONE HYDROCHLORIDE drug variants containing BUTYL ALCOHOL
ZIPRASIDONE HYDROCHLORIDE drug variants not containing BUTYL ALCOHOL
Excipient focus: CALCIUM SILICATE
ZIPRASIDONE HYDROCHLORIDE drug variants containing CALCIUM SILICATE
ZIPRASIDONE HYDROCHLORIDE drug variants not containing CALCIUM SILICATE
Excipient focus: CARBOXYMETHYLCELLULOSE
ZIPRASIDONE HYDROCHLORIDE drug variants containing CARBOXYMETHYLCELLULOSE
ZIPRASIDONE HYDROCHLORIDE drug variants not containing CARBOXYMETHYLCELLULOSE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
ZIPRASIDONE HYDROCHLORIDE drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Wockhardt Limited | ziprasidone hydrochloride | 55648-991 |
| Wockhardt USA LLC | ziprasidone hydrochloride | 64679-991 |
| TYA Pharmaceuticals | ziprasidone hydrochloride | 64725-0994 |
| >Company | >Ingredient | >NDC |
ZIPRASIDONE HYDROCHLORIDE drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CITRIC ACID MONOHYDRATE
ZIPRASIDONE HYDROCHLORIDE drug variants containing CITRIC ACID MONOHYDRATE
ZIPRASIDONE HYDROCHLORIDE drug variants not containing CITRIC ACID MONOHYDRATE
Excipient focus: ETHYLCELLULOSE
ZIPRASIDONE HYDROCHLORIDE drug variants containing ETHYLCELLULOSE
ZIPRASIDONE HYDROCHLORIDE drug variants not containing ETHYLCELLULOSE
Excipient focus: FD&C BLUE NO. 1
ZIPRASIDONE HYDROCHLORIDE drug variants containing FD&C BLUE NO. 1
ZIPRASIDONE HYDROCHLORIDE drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C BLUE NO. 2
ZIPRASIDONE HYDROCHLORIDE drug variants containing FD&C BLUE NO. 2
ZIPRASIDONE HYDROCHLORIDE drug variants not containing FD&C BLUE NO. 2
Excipient focus: FD&C RED NO. 3
ZIPRASIDONE HYDROCHLORIDE drug variants containing FD&C RED NO. 3
ZIPRASIDONE HYDROCHLORIDE drug variants not containing FD&C RED NO. 3
Excipient focus: FD&C RED NO. 40
ZIPRASIDONE HYDROCHLORIDE drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | ziprasidone hydrochloride | 42254-169 |
| LUPIN LIMITED | ziprasidone hydrochloride | 57297-331 |
| BluePoint Laboratories | ziprasidone hydrochloride | 68001-136 |
| Lupin Pharmaceuticals Inc | ziprasidone hydrochloride | 68180-331 |
| >Company | >Ingredient | >NDC |
ZIPRASIDONE HYDROCHLORIDE drug variants not containing FD&C RED NO. 40
Excipient focus: FERRIC OXIDE RED
ZIPRASIDONE HYDROCHLORIDE drug variants containing FERRIC OXIDE RED
ZIPRASIDONE HYDROCHLORIDE drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
ZIPRASIDONE HYDROCHLORIDE drug variants containing FERRIC OXIDE YELLOW
ZIPRASIDONE HYDROCHLORIDE drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: FERROSOFERRIC OXIDE
ZIPRASIDONE HYDROCHLORIDE drug variants containing FERROSOFERRIC OXIDE
ZIPRASIDONE HYDROCHLORIDE drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: GELATIN
ZIPRASIDONE HYDROCHLORIDE drug variants containing GELATIN
ZIPRASIDONE HYDROCHLORIDE drug variants not containing GELATIN
Excipient focus: ISOPROPYL ALCOHOL
ZIPRASIDONE HYDROCHLORIDE drug variants containing ISOPROPYL ALCOHOL
ZIPRASIDONE HYDROCHLORIDE drug variants not containing ISOPROPYL ALCOHOL
Excipient focus: LACTOSE
ZIPRASIDONE HYDROCHLORIDE drug variants containing LACTOSE
ZIPRASIDONE HYDROCHLORIDE drug variants not containing LACTOSE
Excipient focus: LACTOSE MONOHYDRATE
ZIPRASIDONE HYDROCHLORIDE drug variants containing LACTOSE MONOHYDRATE
ZIPRASIDONE HYDROCHLORIDE drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
ZIPRASIDONE HYDROCHLORIDE drug variants containing MAGNESIUM STEARATE
ZIPRASIDONE HYDROCHLORIDE drug variants not containing MAGNESIUM STEARATE
Excipient focus: POLYETHYLENE GLYCOL
ZIPRASIDONE HYDROCHLORIDE drug variants containing POLYETHYLENE GLYCOL
ZIPRASIDONE HYDROCHLORIDE drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYSORBATE 80
ZIPRASIDONE HYDROCHLORIDE drug variants containing POLYSORBATE 80
ZIPRASIDONE HYDROCHLORIDE drug variants not containing POLYSORBATE 80
Excipient focus: POTASSIUM HYDROXIDE
ZIPRASIDONE HYDROCHLORIDE drug variants containing POTASSIUM HYDROXIDE
ZIPRASIDONE HYDROCHLORIDE drug variants not containing POTASSIUM HYDROXIDE
Excipient focus: POVIDONE
ZIPRASIDONE HYDROCHLORIDE drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| REMEDYREPACK INC | ziprasidone hydrochloride | 70518-2367 |
| >Company | >Ingredient | >NDC |
ZIPRASIDONE HYDROCHLORIDE drug variants not containing POVIDONE
Excipient focus: POVIDONE K30
ZIPRASIDONE HYDROCHLORIDE drug variants containing POVIDONE K30
ZIPRASIDONE HYDROCHLORIDE drug variants not containing POVIDONE K30
Excipient focus: PROPYLENE GLYCOL
ZIPRASIDONE HYDROCHLORIDE drug variants containing PROPYLENE GLYCOL
ZIPRASIDONE HYDROCHLORIDE drug variants not containing PROPYLENE GLYCOL
Excipient focus: SHELLAC
ZIPRASIDONE HYDROCHLORIDE drug variants containing SHELLAC
ZIPRASIDONE HYDROCHLORIDE drug variants not containing SHELLAC
Excipient focus: SILICON DIOXIDE
ZIPRASIDONE HYDROCHLORIDE drug variants containing SILICON DIOXIDE
ZIPRASIDONE HYDROCHLORIDE drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM HYDROXIDE
ZIPRASIDONE HYDROCHLORIDE drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| REMEDYREPACK INC | ziprasidone hydrochloride | 70518-2367 |
| >Company | >Ingredient | >NDC |
ZIPRASIDONE HYDROCHLORIDE drug variants not containing SODIUM HYDROXIDE
Excipient focus: SODIUM LAURYL SULFATE
ZIPRASIDONE HYDROCHLORIDE drug variants containing SODIUM LAURYL SULFATE
ZIPRASIDONE HYDROCHLORIDE drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
ZIPRASIDONE HYDROCHLORIDE drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
ZIPRASIDONE HYDROCHLORIDE drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: STARCH, CORN
ZIPRASIDONE HYDROCHLORIDE drug variants containing STARCH, CORN
ZIPRASIDONE HYDROCHLORIDE drug variants not containing STARCH, CORN
Excipient focus: STARCH, PREGELATINIZED CORN
ZIPRASIDONE HYDROCHLORIDE drug variants containing STARCH, PREGELATINIZED CORN
| Company | Ingredient | NDC |
|---|---|---|
| LUPIN LIMITED | ziprasidone hydrochloride | 57297-331 |
| >Company | >Ingredient | >NDC |
ZIPRASIDONE HYDROCHLORIDE drug variants not containing STARCH, PREGELATINIZED CORN
Excipient focus: SUCROSE
ZIPRASIDONE HYDROCHLORIDE drug variants containing SUCROSE
ZIPRASIDONE HYDROCHLORIDE drug variants not containing SUCROSE
Excipient focus: TALC
ZIPRASIDONE HYDROCHLORIDE drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Wockhardt Limited | ziprasidone hydrochloride | 55648-991 |
| Wockhardt USA LLC | ziprasidone hydrochloride | 64679-991 |
| TYA Pharmaceuticals | ziprasidone hydrochloride | 64725-0994 |
| >Company | >Ingredient | >NDC |
ZIPRASIDONE HYDROCHLORIDE drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
ZIPRASIDONE HYDROCHLORIDE drug variants containing TITANIUM DIOXIDE
ZIPRASIDONE HYDROCHLORIDE drug variants not containing TITANIUM DIOXIDE
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
